Hexagon Capital Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,353
| Closed | -$498K | – | 455 |
|
|
2025
Q1 | $498K | Buy |
7,353
+674
| +10% | +$45.7K | 0.09% | 103 |
|
|
2024
Q4 | $300K | Buy |
6,679
+1,411
| +27% | +$63.3K | 0.05% | 151 |
|
|
2024
Q3 | $331K | Buy |
5,268
+178
| +3% | +$11.2K | 0.06% | 136 |
|
|
2024
Q2 | $301K | Buy |
5,090
+157
| +3% | +$9.27K | 0.07% | 146 |
|
|
2024
Q1 | $393K | Sell |
4,933
-179
| -4% | -$14.3K | 0.09% | 118 |
|
|
2023
Q4 | $404K | Buy |
5,112
+716
| +16% | +$56.5K | 0.1% | 110 |
|
|
2023
Q3 | $307K | Buy |
4,396
+1,499
| +52% | +$105K | 0.08% | 120 |
|
|
2023
Q2 | $200K | Buy |
2,897
+522
| +22% | +$36.1K | 0.05% | 161 |
|
|
2023
Q1 | $176K | Buy |
2,375
+281
| +13% | +$20.9K | 0.05% | 170 |
|
|
2022
Q4 | $195K | Sell |
2,094
-1,188
| -36% | -$111K | 0.06% | 154 |
|
|
2022
Q3 | $313K | Sell |
3,282
-1,486
| -31% | -$142K | 0.09% | 111 |
|
|
2022
Q2 | $442K | Sell |
4,768
-452
| -9% | -$41.9K | 0.13% | 90 |
|
|
2022
Q1 | $528K | Sell |
5,220
-212
| -4% | -$21.4K | 0.14% | 89 |
|
|
2021
Q4 | $560K | Buy |
5,432
+686
| +14% | +$70.7K | 0.15% | 82 |
|
|
2021
Q3 | $403K | Sell |
4,746
-48
| -1% | -$4.08K | 0.12% | 92 |
|
|
2021
Q2 | $400K | Buy |
4,794
+1,053
| +28% | +$87.9K | 0.11% | 97 |
|
|
2021
Q1 | $281K | Sell |
3,741
-693
| -16% | -$52.1K | 0.08% | 114 |
|
|
2020
Q4 | $302K | Buy |
4,434
+130
| +3% | +$8.85K | 0.09% | 95 |
|
|
2020
Q3 | $249K | Buy |
+4,304
| New | +$249K | 0.08% | 99 |
|